On (b)(6) 2014 our affiliate was contacted by an eye care professional's (ecp) office to report an adverse event.The pt switched to acuvue oasys for astigmatism contact lenses (aofa) due to astigmatism in (b)(6) 2012.The pt wore the cls on a daily wear schedule, replacing the lenses every 2 weeks.The ecp reported that the aofa lenses fit "slightly tight." prior to that the patient (pt) had been successfully wearing daily disposable, spherical contact lenses (cl).The pt had a history of overwearing cls on occasion and a history of neovascularization.Sometime in (b)(6), the patient was reportedly wearing the cls 10 to 12 hours a day and the left eye (os) was reported to be uncomfortable.The pt changed lenses on 2 occasions due to discomfort, deposits and the lenses "feeling gritty." the pt wore glasses for "a couple of days" and then tried a fresh pair of lenses and experienced irritation with those lenses.The ecp said it was about a month from the onset until the pt was seen by the ecp on (b)(6) 2014.The pt was diagnosed with a peripheral corneal ulcer, os, located at 7 o'clock.The pt was referred to a hospital for treatment and was prescribed ciprofloxacin drops.On (b)(6) 2014 the ecp reported the pt was fine at that time and there was no reduction in visual acuity.The ecp believes the pt is continuing to wear cls "although they were uncomfortable and really shouldn't have." "she had very dry eyes and is going through menopause and she did overwear the lenses." additional information has been requested by not received.A dhr was performed and revealed the following information: a lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00fv68 was produced under normal conditions.Product has been requested for evaluation but has not been received at this time.Based on all available information, no causal factors can be determined and no conclusion can be drawn.If additional product or medical information is received, will report within 30 days of receipt.Mdr reportable event rends are reviewed quarterly in franchise management review meetings.
|